Pantroprazole (Protonix)
Pantoprazole, the fourth benzimidazole proton pump inhibitor to become available in the United States, has been marketed for short-term oral treatment of erosive gastroesophageal reflux disease (GERD)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Pantroprazole (Protonix)
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1083
Article Code: 1083a
Date: July 24, 2000
Volume: 42
Pages: 65-66
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1083
Article Code: 1083a
Date: July 24, 2000
Volume: 42
Pages: 65-66
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)